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Dialysis disequilibrium syndrome (DDS) is a serious neurological complication of hemodialysis, and patients with acute brain
injury are at increased risk. We report a case of DDS leading to intracranial hypertension in a patient with anoxic brain injury and
discuss the subsequent dialysis strategy. A 13-year-old girl was admitted after prolonged resuscitation from cardiac arrest. Computed
tomography (CT) revealed an inferior vena cava aneurysm and multiple pulmonary emboli as the likely cause. An intracranial
pressure (ICP)monitor was inserted, and, on day 3, continuous renal replacement therapy (CRRT)was initiated due to acute kidney
injury, during which the patient developed severe intracranial hypertension. CT of the brain showed diffuse cerebral edema. CRRT
was discontinued, sedation was increased, and hypertonic saline was administered, upon which ICP normalized. Due to persistent
hyperkalemia and overhydration, ultrafiltration and intermittent hemodialysis were performed separately on day 4 with a small
dialyzer, low blood and dialysate flow, and high dialysate sodium content. During subsequent treatments, isolated ultrafiltration
was well tolerated, whereas hemodialysis was associated with increased ICP necessitating frequent pauses or early cessation of
dialysis. In patients at risk ofDDS, hemodialysis should be performedwith utmost care and continuousmonitoring of ICP should be
considered.
1. Introduction
Dialysis-requiring acute kidney injury (AKI) is a common
occurrence in critically ill patients and is associated with
increased mortality [1]. A rare but serious complication of
dialysis is the so-called dialysis disequilibrium syndrome
(DDS), defined as the occurrence of acute neurological symp-
toms attributed to cerebral edema and increased intracranial
pressure (ICP) during or following dialysis [2]. Patients with
acute brain injury are at increased risk of developing DDS
and present a challenge when dialysis is indicated, as the
need for acute dialysis must be balanced against the risk
of neurological deterioration. Here, we present a case of
intracranial hypertension due toDDS in a patient with anoxic
brain injury and discuss the management of hemodialysis in
neurocritically ill patients.
2. Case Presentation
A 13-year-old girl with no prior medical history was admitted
to the hospital after resuscitation from cardiac arrest. The
patient had collapsed during physical exercise in school, and
cardiopulmonary resuscitation (CPR) was initiated immedi-
ately by school personnel. Pulseless electrical activity was the
first observed prehospital rhythm. The patient was intubated
by the ambulance staff, and return of spontaneous circulation
was achieved after 35 minutes through CPR and adrenaline
administration.
Upon arrival to our emergency department, the patient
was hemodynamically unstable with a mean arterial pressure
(MAP) of 60–70mmHg and heart rate of 120 bpm. Arterial
blood gases showed a severe combined metabolic and respi-
ratory acidosis with a pH of 6.7, PaCO
2
of 83mmHg (11 kPa),
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Figure 1: (a) Computed tomography of the brain upon arrival, showing no evidence of cerebral edema or infarction. (b) Day 3, after 7 hours
of continuous renal replacement therapy: the scan now shows generalized cerebral edema with effacement of the basal cisterns and reduced
grey-white matter differentiation.
and a blood lactate of 15mmol/L on mechanical ventilation.
Bedside echocardiography revealed a dilated right ventricle
and a mass in the right ventricular outflow tract suggesting
a venous thrombus. Computed tomography (CT) with pul-
monary angiography showed multiple peripheral emboli in
both lungs, and CT of the abdomen and pelvis revealed an
aneurysm of the inferior vena cava as the likely source of
the emboli. CT of the brain showed no evidence of cerebral
edema or infarction (Figure 1(a)). However, based on the
prolonged resuscitation and decreased level of consciousness,
an ICP transducerwas inserted to enable detection of cerebral
edema during the impending deep sedation. Initial ICP
readings were normal (4mmHg).
The patient was transferred to the cardiothoracic inten-
sive care unit (ICU) and a cerebral perfusion pressure
>60mmHg was maintained with infusion of adrenaline and
noradrenaline. Targeted temperature management aiming at
36∘C for 24 hours was initiated, and the patient was started
on high-dose unfractionated heparin due to the pulmonary
emboli. Failed attempts to cannulate both femoral arteries
resulted in bilateral hematoma formation and continued
bleeding from the right femoral artery despite compression
necessitated surgical exploration with repair of the artery and
fasciotomy.
The day after admission, the patient had been hemody-
namically stabilized and weaned off vasopressors. Sedation
was gradually diminished and finally turned off. The patient
demonstrated eye opening upon stimulation, pupils that
were equal and reactive to light, spontaneous breathing, and
a normal swallowing reflex. No spontaneous movements
were observed. ICP was slightly elevated at 10–17mmHg
depending on stimulation and closely related to MAP. Lab-
oratory analyses revealed rising levels of creatinine, urea,
and potassium, and diuresis was low despite stimulation with
furosemide and metolazone. Myoglobin and creatine kinase
were also significantly elevated, suggesting rhabdomyolysis
due to hypoxia, compartment syndrome of the right thigh,
or both.
On the evening of day 3, the patient had a P-creatinine of
5.17mg/dL (457 𝜇mol/L), P-urea of 99mg/dL (35.4mmol/L),
and a P-potassium of 6.0mmol/L despite infusion of glucose
and insulin. The patient was visibly hypervolemic with an
estimated cumulated fluid balance of +12.5 liters. ICP was
stable but slightly elevated at 16–19mmHg, and the patient
was lightly sedated with remifentanil infusion. It was decided
to initiate continuous renal replacement therapy (CRRT),
and a double lumen dialysis catheter was placed in the
right internal jugular vein. The following dialysis settings
were used: Continuous venovenous hemodiafiltration, ST100
dialyzer (Gambro; surface area 1m2, KUF 25mL/(h⋅mmHg)),
blood flow 120mL/min, predilution flow 1000mL/h (Pris-
mocitrate, Gambro), dialysate flow 1000mL/h (Prism0cal
B22, Gambro), and postdilution flow 200mL/h (Phoxillium,
Gambro).
Approximately seven hours after start of CRRT, ICP had
increased to 38mmHg (Figure 2); the patient had devel-
oped diverging eye axes and become unresponsive to pain
(Glasgow Coma Score 3). On suspicion of cerebral edema
or infarction, CRRT was stopped, 50mL of hypertonic
saline (1mmol/mL) was administered, and the patient was
sedated with propofol. CT of the brain was performed and
revealed diffuse cerebral edema (Figure 1(b)). ICP decreased
to 20mmHg within a few hours. Due to the neurological
deterioration and unstable ICP, the patient was transferred to
the neurological ICU (NICU) and sedated with thiopentone,
midazolam, and fentanyl.
On day 4, an external ventricular drain (EVD) was
inserted stereotaxically based on a predicted need for further
hemodialysis, uponwhich ICPdecreased from 10 to 3mmHg.
A window of cardiovascular stability and low ICP was used
as an opportunity to start careful intermittent hemodialysis.
Hemodialysis was chosen over peritoneal dialysis due to
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Figure 2: Intracranial pressure during a 13-hour period after start
of continuous renal replacement therapy. 𝑥-axis denotes time of day.
HD = hemodialysis; NICU = Neurointensive Care Unit.
hyperkalemia and the need for removal of large volumes
of fluid, as well as the possibility of separating ultrafiltra-
tion and dialysis. P-creatinine was 5.92mg/dL (523𝜇mol/L)
and P-urea 95mg/dL (34.1mmol/L) before start of dialysis.
The patient completed 3.5 hours of isolated ultrafiltration,
with ultrafiltration rate gradually increasing from 250mL/h
to 1000mL/h and a total fluid removal of 2.5 L. Sub-
sequently, the patient underwent 1 hour of hemodialysis
without complications and with no clinically significant
changes in ICP. Dialysis settings were modified to reduce
the dialysis dose in an attempt to prevent DDS and were
as follows: H6 dialyzer (Gambro; surface area 0.6m2, KUF
33mL/(h⋅mmHg)), dialysate sodium 148mmol/L, potassium
2mmol/L, bicarbonate 38mmol/L, calcium 1.5mmol/L,mag-
nesium 0.5mmol/L, and low dialysate flow at 300mL/min
and blood flow 150mL/min with concurrent flows to reduce
dialysis efficiency. On day 5, ultrafiltration and hemodialysis
were repeated with similar settings. However, ICP gradually
increased from 0 to 10mmHg and the treatment was stopped
prematurely. Similar problems were encountered on the fol-
lowing days, necessitating frequent pauses or early cessation
of hemodialysis.
On day 8, an inferior vena cava filter was placed in
order to prevent future episodes of pulmonary embolization.
From day 10 and onwards, the patient was able to tolerate
hemodialysis without increases in ICP. Hemodialysis was
discontinued on day 21, as kidney function was rapidly
returning. The patient was gradually weaned off sedation
and mechanical ventilation; autonomic dysfunction ensued
and was treated with baclofen and propranolol. On day
51 the patient was in a minimally conscious state (MCS)
and was discharged from the NICU and transferred to a
neurorehabilitation facility. Upon follow-up three months
after discharge, she remained in MCS with signs of slow
improvement.
3. Discussion
DDS occurs with a wide spectrum of clinical manifestations,
ranging from mild symptoms such as headache, nausea,
vomiting, blurred vision, and muscle twitching to more
severe manifestations including altered mental status, coma,
seizures, and death [2]. The diagnosis is largely clinical, but
the syndrome has been associated with electroencephalo-
graphic abnormalities [3], and diagnostic imaging of the
brain may reveal changes consistent with cerebral edema [4].
The pathophysiology of DDS remains debated, but it likely
involves an osmotic shift of water across the blood-brain
barrier into the brain due to a rapid removal of urea from
plasma during dialysis [5]. DDS seems to be more common
in children, in patients with very high blood urea concentra-
tions, in patients with chronic kidney disease (versus AKI),
and in patients undergoing their first dialysis [2, 6]. A number
of cases of DDS have been reported in patients with traumatic
brain injury and intracranial hemorrhage, suggesting that
patients with acute brain injury are particularly susceptible
to this condition. [7–13]. Several of thementioned risk factors
were present in our patient, most notably anoxic brain injury
due to prolonged cardiac arrest, which resulted in cerebral
edema. In the present case, ICP monitoring aided in the
detection of intracranial hypertension during CRRT and led
to EVD placement and a conservative dialysis strategy.
AKI is a common complication in the course of critical
illness, and dialysis is often indicated due to overhydration,
hyperkalemia, or severe acidosis. To correct these distur-
bances in a clinically appropriate time scale, hemodialysis
(as opposed to peritoneal dialysis) is often the most feasible
option. In patients with acute brain injury, however, caution
should be exhibited due to the risk of DDS and associ-
ated intracranial hypertension. Potential protective strategies
against DDS have been proposed in the literature, includ-
ing slower blood and dialysate flows, smaller surface area
dialyzer membranes, and high sodium and low bicarbonate
concentrations in the dialysate [14]. Furthermore, continuous
therapies (i.e., CRRT) have been suggested as being safer
than intermittent hemodialysis in patients at risk of DDS
[15, 16]. The common rationale behind these strategies is to
slow down the rate of urea clearance, to reduce the change
in serum osmolality, and to maintain hemodynamic stability.
In our patient, however, DDS first developed during CRRT,
indicating that patients are at risk even when using continu-
ous therapies [17]. The patient was subsequently treated with
intermittent hemodialysis, in which dialysis settings were
modified in an attempt to reduce the risk of DDS, including
separation of ultrafiltration and dialysis and modification
of dialysate electrolytes. These precautions allowed sufficient
fluid removal, but hemodialysis was nonetheless complicated
by recurring increases in ICP, necessitating frequent pauses
or early cessation of the treatment.
Hyperosmolar therapy, a mainstay in the treatment of
elevated ICP, is another potential strategy for the manage-
ment of DDS. The treatment can effectively reduce cerebral
edema by raising plasma osmolality, thereby removing brain
extracellular fluid due to creation of an osmotic gradient
across the blood-brain barrier [18]. In the present case,
hypertonic saline was administered during the initial ICP
crisis during CRRT and was effective in reducing ICP,
although discontinuation of dialysis and increased sedation
were likely important as well. As a preventivemeasure against
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DDS, certain authors have suggested infusion of hypertonic
saline during dialysis in high-risk patients [14]. A similar
effect can be achieved using a high sodium dialysate, as
employed in our case. There are, however, potential safety
concerns with hyperosmolar therapy in the setting of renal
failure, as insufficient renal excretion could put patients at
risk of sodium overload and hypervolemia. Few studies have
examined hyperosmolar therapy in this patient population,
although a small retrospective study of hypertonic saline for
treatment of elevated ICP in patients with renal failure found
the treatment to be safe and effective [19].
4. Conclusion
This case highlights the inherent risks associated with hemo-
dialysis in patients with acute brain injury. The patient
in question was likely predisposed to DDS due to anoxic
brain injury and cerebral edema after prolonged cardiac
arrest. Increases in ICP developed both during CRRT and
during careful intermittent hemodialysis, indicating that no
dialysis modality confers complete protection against this
complication. In high-risk patients, we suggest early start of
dialysis to avoid high urea gradients during the procedure, as
well as minimizing the dialysis dose. Isolated ultrafiltration
seems to be well tolerated and may allow correction of
fluid overload. If hemodialysis is required in the high-risk
neurocritically ill patient, continuous ICP monitoring may
be required to enable timely detection of and intervention
against DDS.
Conflicts of Interest
The authors have no conflicts of interest to report.
References
[1] S. Uchino, J. A. Kellum, R. Bellomo et al., “Acute renal failure
in critically ill patients: A Multinational, Multicenter Study,”
Journal of the American Medical Association, vol. 294, no. 7, pp.
813–818, 2005.
[2] N. Patel, P. Dalal, and M. Panesar, “Dialysis disequilibrium
syndrome: a narrative review,” Seminars in Dialysis, vol. 21, no.
5, pp. 493–498, 2008.
[3] H. Hampl, H. W. Klopp, N. Michels et al., “Electroencephalo-
gram investigations of the disequilibrium syndrome during
bicarbonate and acetate dialysis,” Proceedings of the European
Dialysis and Transplant Association, vol. 19, pp. 351–359, 1983.
[4] R. J. L. Walters, N. C. Fox, W. R. Crum, D. Taube, and D. J.
Thomas, “Haemodialysis and cerebral oedema,” Nephron, vol.
87, no. 2, pp. 143–147, 2001.
[5] S. M. Silver, R. H. Sterns, and M. L. Halperin, “Brain swelling
after dialysis: old urea or new osmoles?” American Journal of
Kidney Diseases, vol. 28, no. 1, pp. 1–13, 1996.
[6] A. I. Arieff, “Dialysis disequilibrium syndrome: current con-
cepts on pathogenesis and prevention,” Kidney International,
vol. 45, no. 3, pp. 629–635, 1994.
[7] S. Yoshida, T. Tajika, N. Yamasaki et al., “Dialysis dysequilib-
rium syndrome in neurosurgical patients,” Neurosurgery, vol.
20, no. 5, pp. 716–721, 1987.
[8] N. K. Krane, “Intracranial pressure measurement in a patient
undergoing hemodialysis and peritoneal dialysis,” American
Journal of Kidney Diseases, vol. 13, no. 4, pp. 336–339, 1989.
[9] M. Thicoipe, H. P. Stoiber, P. Maurette, A. Leger, and J.
F. Cochard, “Changes in intracranial pressure in severe
head injured patients in hemodialysis,” Annales Franc¸aises
d’Anesthe´sie et de Re´animation, vol. 7, pp. 336–338, 1988.
[10] C. M. Lin, J. W. Lin, J. T. Tsai et al., “Intracranial pressure
fluctuation during hemodialysis in renal failure patients with
intracranial hemorrhage,” Acta Neurochirurgica Supplement,
vol. 101, pp. 141–144, 2008.
[11] P. Esnault, G. Lacroix, P.-J. Cungi, E. D’Aranda, J. Cotte, and P.
Goutorbe, “Dialysis disequilibrium syndrome inneurointensive
care unit: the benefit of intracranial pressure monitoring,”
Critical Care, vol. 16, no. 6, article 472, 2012.
[12] Y. M. Bertrand, A. Hermant, P. Mahieu, and J. Roels, “Intracra-
nial pressure changes in patients with head trauma during
haemodialysis,” Intensive Care Medicine, vol. 9, no. 6, pp. 321–
323, 1983.
[13] M. Osgood, R. Compton, R. Carandang, W. Hall, G. Kershaw,
and S. Muehlschlegel, “Rapid unexpected brain herniation
in association with renal replacement therapy in acute brain
injury: caution in the neurocritical care unit,” Neurocritical
Care, vol. 22, no. 2, pp. 176–183, 2015.
[14] A. Davenport, “Practical guidance for dialyzing a hemodialysis
patient following acute brain injury,” Hemodialysis Interna-
tional, vol. 12, no. 3, pp. 307–312, 2008.
[15] A. Davenport, “Continuous renal replacement therapies in
patients with acute neurological injury,” Seminars in Dialysis,
vol. 22, no. 2, pp. 165–168, 2009.
[16] J. J. Fletcher, K. Bergman, E. C. Feucht, and P. Blostein, “Con-
tinuous renal replacement therapy for refractory intracranial
hypertension,”Neurocritical Care, vol. 11, no. 1, pp. 101–105, 2009.
[17] S. Tuchman, Z. P. Khademian, and K. Mistry, “Dialysis disequi-
librium syndrome occurring during continuous renal replace-
ment therapy,”Clinical Kidney Journal, vol. 6, no. 5, pp. 526–529,
2013.
[18] A. Torre-Healy, N. F. Marko, and R. J. Weil, “Hyperosmolar
therapy for intracranial hypertension,” Neurocritical Care, vol.
17, no. 1, pp. 117–130, 2012.
[19] K. G. Hirsch, T. Spock, M. A. Koenig, and R. G. Geocadin,
“Treatment of elevated intracranial pressure with hyperosmolar
therapy in patients with renal failure,”Neurocritical Care, vol. 17,
no. 3, pp. 388–394, 2012.
Submit your manuscripts at
https://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
